• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒逃避短干扰RNA所需的序列同源性。

Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.

作者信息

Sabariegos Rosario, Giménez-Barcons Mireia, Tàpia Natalia, Clotet Bonaventura, Martínez Miguel Angel

机构信息

Fundació irsiCaixa, Laboratori de Retrovirologia, Hospital Universitari Germans Trias i Pujol, Ctra del Canyet s/n, 08916 Badalona, Spain.

出版信息

J Virol. 2006 Jan;80(2):571-7. doi: 10.1128/JVI.80.2.571-577.2006.

DOI:10.1128/JVI.80.2.571-577.2006
PMID:16378959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1346856/
Abstract

Short interfering RNAs (siRNAs) targeting viral or cellular genes can efficiently inhibit human immunodeficiency virus type 1 (HIV-1) replication. Nevertheless, the emergence of mutations in the gene being targeted could lead to the rapid escape from the siRNA. Here, we simulate viral escape by systematically introducing single-nucleotide substitutions in all 19 HIV-1 residues targeted by an effective siRNA. We found that all mutant viruses that were tested replicated better in the presence of the siRNA than in the presence of the wild-type virus. The antiviral activity of the siRNA was completely abolished by single substitutions in 10 (positions 4 to 11, 14, and 15) out of 16 positions tested (substitution at 3 of the 19 positions explored rendered nonviable viruses). With the exception of the substitution observed at position 12, substitutions at either the 5' end or the 3' end (positions 1 to 3, 16, and 18) were better tolerated by the RNA interference machinery and only in part affected siRNA inhibition. Our results show that optimal HIV-1 gene silencing by siRNA requires a complete homology within most of the target sequence and that substitutions at only a few positions at the 5' and 3' ends are partially tolerated.

摘要

靶向病毒或细胞基因的小干扰RNA(siRNA)能够有效抑制1型人类免疫缺陷病毒(HIV-1)的复制。然而,被靶向基因中突变的出现可能导致病毒迅速逃离siRNA的作用。在此,我们通过在一种有效siRNA靶向的所有19个HIV-1残基中系统性地引入单核苷酸替换来模拟病毒逃逸。我们发现,所有经测试的突变病毒在siRNA存在的情况下比在野生型病毒存在的情况下复制得更好。在测试的16个位置中,有10个位置(第4至11位、第14位和第15位)的单碱基替换完全消除了siRNA的抗病毒活性(在探索的19个位置中有3个位置的替换产生了无活力的病毒)。除了在第12位观察到的替换外,5'端或3'端(第1至3位、第16位和第18位)的替换更能被RNA干扰机制耐受,并且只是部分影响siRNA的抑制作用。我们的结果表明,siRNA实现最佳的HIV-1基因沉默需要在大部分靶序列内具有完全同源性,并且在5'端和3'端只有少数几个位置的替换能被部分耐受。

相似文献

1
Sequence homology required by human immunodeficiency virus type 1 to escape from short interfering RNAs.1型人类免疫缺陷病毒逃避短干扰RNA所需的序列同源性。
J Virol. 2006 Jan;80(2):571-7. doi: 10.1128/JVI.80.2.571-577.2006.
2
Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.靶向高度保守引物结合位点的小干扰RNA对1型人类免疫缺陷病毒复制的抑制作用
Virology. 2004 Dec 5;330(1):221-32. doi: 10.1016/j.virol.2004.09.027.
3
Inhibition of drug-resistant HIV-1 by RNA interference.RNA干扰对耐药性HIV-1的抑制作用。
Antiviral Res. 2006 Jan;69(1):1-8. doi: 10.1016/j.antiviral.2005.10.001. Epub 2005 Nov 2.
4
RNA interference as a tool for exploring HIV-1 robustness.RNA 干扰作为一种探索 HIV-1 稳健性的工具。
J Mol Biol. 2011 Oct 14;413(1):84-96. doi: 10.1016/j.jmb.2011.08.035. Epub 2011 Aug 22.
5
Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.靶向人类免疫缺陷病毒1型多个高度保守RNA序列的慢病毒小干扰RNA
Gene Ther. 2005 Jul;12(14):1133-44. doi: 10.1038/sj.gt.3302509.
6
Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.小干扰RNA在人外周血单个核细胞中对HIV-1 env基因的特异性沉默作用
Gene Ther. 2003 Nov;10(24):2046-50. doi: 10.1038/sj.gt.3302099.
7
Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.针对TAR RNA结合蛋白TRBP(一种Dicer辅助因子)的小分子干扰RNA可抑制1型人类免疫缺陷病毒长末端重复序列的表达及病毒产生。
J Virol. 2007 May;81(10):5121-31. doi: 10.1128/JVI.01511-06. Epub 2007 Mar 14.
8
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.人类免疫缺陷病毒1型(HIV-1)可通过在其RNA基因组中形成一种替代结构来逃避RNA干扰。
Nucleic Acids Res. 2005 Feb 1;33(2):796-804. doi: 10.1093/nar/gki220. Print 2005.
9
Silencing of HIV-1 with RNA interference: a multiple shRNA approach.利用RNA干扰沉默HIV-1:一种多短发夹RNA方法。
Mol Ther. 2006 Dec;14(6):883-92. doi: 10.1016/j.ymthe.2006.07.007. Epub 2006 Sep 7.
10
Endoribonuclease-prepared short interfering RNAs induce effective and specific inhibition of human immunodeficiency virus type 1 replication.核糖核酸酶制备的短干扰RNA可有效且特异性地抑制1型人类免疫缺陷病毒的复制。
J Virol. 2007 Oct;81(19):10680-6. doi: 10.1128/JVI.00950-07. Epub 2007 Jul 25.

引用本文的文献

1
RNA Viruses and RNAi: Quasispecies Implications for Viral Escape.RNA病毒与RNA干扰:准种对病毒逃逸的影响
Viruses. 2015 Jun 19;7(6):3226-40. doi: 10.3390/v7062768.
2
Engineering T Cells to Functionally Cure HIV-1 Infection.工程化改造T细胞以功能性治愈HIV-1感染。
Mol Ther. 2015 Jul;23(7):1149-1159. doi: 10.1038/mt.2015.70. Epub 2015 Apr 21.
3
A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA.HIV-1 gag RNA 中的保守靶位可被 HDV 核酶和短发夹 RNA 同时抑制。
Mol Ther Nucleic Acids. 2014 Jul 29;3(7):e178. doi: 10.1038/mtna.2014.31.
4
Multiple microRNAs targeted to internal ribosome entry site against foot-and-mouth disease virus infection in vitro and in vivo.针对体内外口蹄疫病毒感染的靶向内部核糖体进入位点的多个 microRNA。
Virol J. 2014 Jan 6;11:1. doi: 10.1186/1743-422X-11-1.
5
Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology.利用 RNA 干扰 (RNAi) 技术对抗 HIV-1 的抗病毒策略。
Evol Bioinform Online. 2013 May 16;9:203-13. doi: 10.4137/EBO.S11412. Print 2013.
6
Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents.猪干扰素-α与抗病毒药物联合增强对口蹄疫病毒的抑制作用。
Antiviral Res. 2012 Nov;96(2):213-20. doi: 10.1016/j.antiviral.2012.09.009. Epub 2012 Sep 21.
7
Creating genetic resistance to HIV.创造对 HIV 的遗传抵抗力。
Curr Opin Immunol. 2012 Oct;24(5):625-32. doi: 10.1016/j.coi.2012.08.013. Epub 2012 Sep 15.
8
Endogenous MCM7 microRNA cluster as a novel platform to multiplex small interfering and nucleolar RNAs for combinational HIV-1 gene therapy.内源性 MCM7 microRNA 簇作为一种新型平台,用于组合 HIV-1 基因治疗中的小干扰 RNA 和核仁 RNA。
Hum Gene Ther. 2012 Nov;23(11):1200-8. doi: 10.1089/hum.2012.011. Epub 2012 Sep 18.
9
Current progress and challenges in HIV gene therapy.HIV基因治疗的当前进展与挑战。
Future Virol. 2011 Nov 1;6(11):1319-1328. doi: 10.2217/fvl.11.113.
10
Ultradeep sequencing analysis of population dynamics of virus escape mutants in RNAi-mediated resistant plants.利用 RNAi 介导抗性植物中病毒逃逸突变体的种群动态的超深度测序分析。
Mol Biol Evol. 2012 Nov;29(11):3297-307. doi: 10.1093/molbev/mss135. Epub 2012 May 15.

本文引用的文献

1
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.有证据表明HIV-1编码一种小干扰RNA和一种RNA沉默抑制因子。
Immunity. 2005 May;22(5):607-19. doi: 10.1016/j.immuni.2005.03.010.
2
Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region.丙型肝炎病毒复制子可逃避由针对NS5b编码区的短干扰RNA所诱导的RNA干扰。
J Virol. 2005 Jun;79(11):7050-8. doi: 10.1128/JVI.79.11.7050-7058.2005.
3
Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV.慢病毒介导短发夹RNA可保护多种进化枝及HIV原代分离株感染的CD4 T细胞。
Blood. 2005 Aug 1;106(3):818-26. doi: 10.1182/blood-2004-10-3959. Epub 2005 Apr 14.
4
A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.对活性小干扰RNA(siRNA)在所有单核苷酸错配靶位点的沉默效果进行的系统分析。
Nucleic Acids Res. 2005 Mar 21;33(5):1671-7. doi: 10.1093/nar/gki312. Print 2005.
5
HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.人类免疫缺陷病毒1型(HIV-1)可通过在其RNA基因组中形成一种替代结构来逃避RNA干扰。
Nucleic Acids Res. 2005 Feb 1;33(2):796-804. doi: 10.1093/nar/gki220. Print 2005.
6
The silent revolution: RNA interference as basic biology, research tool, and therapeutic.沉默革命:RNA干扰作为基础生物学、研究工具及治疗手段
Annu Rev Med. 2005;56:401-23. doi: 10.1146/annurev.med.56.082103.104606.
7
Updated European recommendations for the clinical use of HIV drug resistance testing.欧洲关于HIV耐药性检测临床应用的更新建议。
Antivir Ther. 2004 Dec;9(6):829-48.
8
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.合成双链RNA Dicer底物可增强RNA干扰的效力和效果。
Nat Biotechnol. 2005 Feb;23(2):222-6. doi: 10.1038/nbt1051. Epub 2004 Dec 26.
9
Synthetic shRNAs as potent RNAi triggers.合成短发夹RNA作为有效的RNA干扰触发因子。
Nat Biotechnol. 2005 Feb;23(2):227-31. doi: 10.1038/nbt1052. Epub 2004 Dec 26.
10
Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches.脊髓灰质炎病毒对RNA干扰的逃逸:小干扰RNA靶向识别及其对治疗方法的影响
J Virol. 2005 Jan;79(2):1027-35. doi: 10.1128/JVI.79.2.1027-1035.2005.